Dexamethasone in Patients with Glioblastoma: A Systematic Review and Meta-Analysis.

Despite the widespread use of dexamethasone in glioblastoma patients, its use is correlated with worse long-term outcomes. Consequently, Dexamethasone administration should be restricted to selected symptomatic patients. Future prospective studies are crucial to confirm these findings.